The Regenovue series features a monophasic structure manufactured with advanced BDDE cross-linking technology. It offers high viscoelasticity and cohesiveness for smooth, uniform injection. This specific line maintains an exceptionally low endotoxin level (<0.0015 IU/mg) to minimize the risk of inflammation and adverse reactions.
Quick Version Comparison
Feature
Regenovue FINE
Regenovue Deep
Regenovue Sub-Q
Formulation Type
Low Viscosity Gel (Soft)
Medium Viscosity Gel (Medium)
High Viscosity Gel (Hard)
HA Concentration
24mg/ml HA (No Lidocaine)
24mg/ml HA (No Lidocaine)
24mg/ml HA (No Lidocaine)
Target Depth
Superficial Dermis
Mid to Deep Dermis
Deep Dermis / Subcutaneous
Product Identification
Regenovue FINE
Low Viscosity Gel
Total Volume/Content
1.0ml × 1 Syringe (Per Box)
Core Ingredients & Technical Details
Primary Active Ingredients
Cross-linked Hyaluronic Acid 24mg/ml
Mechanism of Action
Injected into the superficial layers of the dermis to fill fine tissue depressions and physically smooth the skin surface.
100% Cross-linked HA (BDDE)Smooth Monophasic StructureFine Particle Size
Efficacy Summary & Expected Benefits
Main Effects and Benefits
Correction of fine lines and superficial wrinkles, skin texture refinement, and delicate volume restoration.
Supplied as a sterile, pre-filled syringe. Typically administered using a 30G needle.
Storage & Handling Instructions
Required Storage Temperature
2°C ~ 25°C (Do not freeze, protect from direct sunlight)
Shelf Life
24 months from the date of manufacture.
Precautions & Safety Notes
Contraindications Patients with a history of hypersensitivity to HA, pregnant or breastfeeding women, and those with severe inflammatory skin conditions.
Safety Warnings Over-injection in very thin skin may cause the Tyndall effect (a bluish tint). Intravascular injection is strictly prohibited.
Common Temporary Side Effects
Temporary erythema
Swelling and bruising
Mild pain at the injection site
Product Identification
Regenovue Deep
Medium Viscosity Gel
Total Volume/Content
1.0ml × 1 Syringe (Per Box)
Core Ingredients & Technical Details
Primary Active Ingredients
Cross-linked Hyaluronic Acid 24mg/ml
Mechanism of Action
Injected into the mid-to-deep dermis to elevate deeper skin depressions and restore lost volume. Features a balanced structure combining softness and elasticity with a dense cross-linking matrix.
100% Cross-linked HA (BDDE)Medium Particle SizeExcellent Shape Retention
Efficacy Summary & Expected Benefits
Main Effects and Benefits
Correction of moderate to deep wrinkles, lip augmentation, and natural volume enhancement of facial contours.
Recommended/Targeted Areas of Use
Nasolabial folds, marionette lines, deep forehead wrinkles, lips, and cheeks.
Usage Protocol & Application Guide
Recommended Application Method
Injection into the Mid to Deep Dermis.
Onset and Duration of Effect
Approximately 8 to 12 months.
Preparation Instructions
Supplied as a sterile, pre-filled syringe. Typically administered using a 27G needle.
Storage & Handling Instructions
Required Storage Temperature
2°C ~ 25°C (Store at room temperature)
Shelf Life
24 months from the date of manufacture.
Precautions & Safety Notes
Contraindications Patients with HA allergies or active infections/inflammation at the proposed injection site.
Safety Warnings Must be injected at the correct depth; superficial injection of a medium-particle filler may result in visible or palpable lumps.
Common Temporary Side Effects
Temporary swelling and bruising
Tenderness and redness at the injection site
Product Identification
Regenovue Sub-Q
High Viscosity Gel
Total Volume/Content
1.0ml × 1 Syringe (Per Box)
Core Ingredients & Technical Details
Primary Active Ingredients
Cross-linked Hyaluronic Acid 24mg/ml
Mechanism of Action
Forms a sturdy support structure in the deep dermis or subcutaneous layer to induce distinct three-dimensional projection and structural lifting. Possesses the highest degree of cross-linking and viscoelasticity in the series.
100% Cross-linked HA (BDDE)Large Particle SizeStrong Resistance to Pressure
Efficacy Summary & Expected Benefits
Main Effects and Benefits
Facial contouring, restoration of severe volume deficits, structural shaping, and correction of very deep folds.
Recommended/Targeted Areas of Use
Chin, nose bridge, jawline, cheekbones, and severe nasolabial folds.
Usage Protocol & Application Guide
Recommended Application Method
Injection into the Deep Dermis, Subcutaneous layer, or Supraperiosteal plane.
Onset and Duration of Effect
Approximately 8 to 12 months (varies depending on individual metabolism and injection site).
Preparation Instructions
Due to the high viscosity and large particle size, an appropriately sized needle or cannula (typically 25G or 27G) should be used.
Storage & Handling Instructions
Required Storage Temperature
2°C ~ 25°C
Shelf Life
24 months from the date of manufacture.
Precautions & Safety Notes
Contraindications Patients with bleeding disorders, a tendency to form keloids, or a history of severe allergies.
Safety Warnings Strict aspiration is required to prevent vascular occlusion, tissue necrosis, or blindness, particularly in high-risk areas with complex vasculature like the nose and glabella.
